place, both of these region almost acquired almost same market shares. Asia Pacific expected to emerge as most lucrative market over the forthcoming years. Improved medical and healthcare infrastructure, rise in public and private investment in life science research, technological advancements in the treatment of GI diseases in emerging economies have made this region favorable and to grow at highest CAGR.
Companies Profiled:
The companies covered in the report include Abbott Laboratories, Allergan Plc, AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., Janssen Biotech Inc., Sanofi, Takeda Pharmaceutical, and Valeant Pharmaceuticals Inc.
Click the Below Full Report:-
https:// www. infiniumglobalresearch. com / healthcare _ medical _ devices / global _ gastroi ntestinal _ drugs _ market
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of gastrointestinal drugs globally as well as regionally.